Eyetas Therapeutics was founded by Dr. Tassos Georgiou to revolutionize eye health through science-driven innovation. With millions suffering from age-related macular degeneration (AMD) and Stargardt’s disease, our mission is to address the unmet needs in ophthalmology. Our team of leading scientists and healthcare experts developed Eyetas, a pharmaceutical-grade Omega-3 supplement formulated with highly purified EPA and DHA, essential for eye health.
Clinical and preclinical studies indicate promising results, reinforcing its potential to maintain and improve vision. With a commitment to innovation, Eyetas Therapeutics is redefining eye care by delivering research-backed solutions that help protect vision where it’s needed most.
Millions worldwide face vision loss from these conditions, yet few effective options exist. However, Eyetas offers a proactive approach, providing targeted nutritional support designed to preserve sight. By combining science and patient care, we are shaping the future of ophthalmology. Discover how Eyetas is bringing new hope to eye health.
Email: Info@eyetas.com
